(Q53656768)

16 May 2018

title

Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. (English)

1 reference

16 May 2018

0 references

1 reference

1 reference

Zhong-chuan Lv

1

1 reference

16 May 2018

Yong-sheng Fan

series ordinal

2

1 reference

16 May 2018

Hong-bing Chen

series ordinal

3

1 reference

16 May 2018

Da-wei Zhao

series ordinal

4

1 reference

16 May 2018

publication date

21 December 2014

1 reference

16 May 2018

published in

Tumor Biology

1 reference

16 May 2018

volume

36

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

1619-1625

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-014-2760-9

exact match

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

miR-155 as a diagnostic and prognostic marker in hematological and solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA-143 and -145 in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Cell-free Circulating miRNA Biomarkers in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Predicting distant metastasis and chemoresistance using plasma miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

Serum microRNA-155 as a potential biomarker to track disease in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2760-9

The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis

21 January 2018

1 reference

12 December 2020

Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression

1 reference

12 December 2020

Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients

1 reference

12 December 2020

[Expression and its clinical significance of hsa-miR-155 in serum of endometrial cancer]

1 reference

12 December 2020

MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential.

1 reference

12 December 2020

CEA monitoring in colorectal cancer. What you should know.

1 reference

12 December 2020

10.1007/S13277-014-2760-9

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25528214

1 reference

16 May 2018